[Impact in the adult population of immunization with nirsevimab in children under 6 months of age against respiratory syncytial virus].

fernando

June 30, 2025

1:05 pm

Reina J; Viana-Ramirez J

Abstract: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia: 2024 doi: 10.37201/req/049.2024 https://pubmed.ncbi.nlm.nih.gov/39010814

Category : Publications

Tags : 2024

@arpbigidisba

arpbigidisba @arpbigidisba ·

19 Jul

La pasada semana nuestra compañera @EscobarSalom ha participado en el congreso #FEMSmicro2025 que ha tenido lugar en Milán, Italia.

Last week, our labmate @EscobarSalom has participated in #FEMSmicro2025 congress in Milan, Italy.

Reply on Twitter 1946483408185491670 Retweet on Twitter 1946483408185491670 2 Like on Twitter 1946483408185491670 5 X 1946483408185491670

arpbigidisba @arpbigidisba ·

11 Jul

Notícia completa 👇🏻
https://diari.uib.es/Hemeroteca/Un-sistema-pionero-permite-predecir-la-resistencia.cid809294

Reply on Twitter 1943719646395293891 Retweet on Twitter 1943719646395293891 1 Like on Twitter 1943719646395293891 4 X 1943719646395293891

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

10 Jul

Nou article a #Docusalut: 🦠🏥 Analysis of intrahospital and global dissemination and resistome dynamics of NDM-1-producing ST773 high-risk clone http://hdl.handle.net/20.500.13003/24750 @microHUSE @carla_lc2911 @aoliverp73 @idisbaib #PublicaSalutIB

Reply on Twitter 1943339897332363707 Retweet on Twitter 1943339897332363707 4 Like on Twitter 1943339897332363707 4 X 1943339897332363707

Retweet on Twitter arpbigidisba Retweeted

Infosalut @infosalut ·

7 Jul

#PublicaSalutIB @microHUSE i @idisbaib ha participat en la publicació d'un estudi sobre l'ús de la ceftazidima-avibactam indueix multiresistència i limita teràpies col·laterals contra P. aeruginosa https://www.infosalut.com/investigacio/estudis-i-projectes/17616 https://doi.org/10.1038/s41467-025-58597-6

@aoliverp73 @sonespases

Reply on Twitter 1942177351510503830 Retweet on Twitter 1942177351510503830 3 Like on Twitter 1942177351510503830 3 X 1942177351510503830

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

1 Jul

Nou article a #Docusalut: 💊🦠 Ceftazidime-avibactam use selects multidrug-resistance and prevents designing collateral sensitivity-based therapies against Pseudomonas aeruginosa http://hdl.handle.net/20.500.13003/24711 @microHUSE @sonespases @idisbaib #PublicaSalutIB

Reply on Twitter 1940040618232738063 Retweet on Twitter 1940040618232738063 3 Like on Twitter 1940040618232738063 2 X 1940040618232738063

arpbigidisba @arpbigidisba ·

2 Jul

The “2nd Hands On Workshop on Pseudomonas aeruginosa Resistance Phenotypes and Whole Genome Sequence Resistome Analysis” will begin in 2 months. This ESCMID workshop is organized by members of our group and will take place at the facilities of the Son Espases University Hospital.

Reply on Twitter 1940426817627918815 Retweet on Twitter 1940426817627918815 3 Like on Twitter 1940426817627918815 4 X 1940426817627918815

Related

Reina J; Viana-Ramirez J

Related

Related

2nd Hands On Workshop on Pseudomonas Aeruginosa Resistance Phenotypes and Whole Genome Sequence Resistome Analysis

Contact